Medovate is an innovation development company dedicated to the commercialisation of pioneering medical technologies created within the NHS.
Backed with £9 million of investment capital, Medovate
identifies and works with high potential medtech innovations. Medovate
inject the specialist management resources and finance required to
support innovation development through clinical trials and regulatory
By providing funding and support at a crucial point in
the development of innovative medical technologies, Medovate accelerates
innovations to market in order to benefit patient care and healthcare
For further information and to register for updates please visit the dedicated Medovate website.